Search Results - "Hamano, Shingo"

Therapeutic Effects of Biobran, Modified Arabinoxylan Rice Bran, in Improving Symptoms of Diarrhea Predominant or Mixed Type Irritable Bowel Syndrome: A Pilot, Randomized Controlled Study by Tsukamoto, Hironobu, Mizoshita, Tsutomu, Kubota, Eiji, Tanida, Satoshi, Kataoka, Hiromi, Okuda, Noriaki, Joh, Takashi, Nishiwaki, Hirotaka, Hamano, Shingo, Katano, Takahito, Ebi, Masahide, Ozeki, Keiji, Tanaka, Mamoru, Shikano, Michiko, Kamiya, Takeshi, Mori, Yoshinori

“…Background. Recently, it was revealed that low grade mucosal inflammation and/or immune imbalance of the lower digestive tract is one of the mechanisms…”
Get full text

A Case of Conversion Surgery for an Initially Locally Advanced Unresectable Pancreatic Cancer after S-1 Chemotherapy by Hayashi, Yuichi, Matsuo, Yoichi, Hamano, Shingo, Oba, Anri, Ueda, Goro, Omi, Kan, Imafuji, Hiroyuki, Saito, Kenta, Tsuboi, Ken, Morimoto, Mamoru, Ogawa, Ryo, Takahashi, Hiroki, Takiguchi, Shuji

“…We report a case of conversion surgery for a locally advanced unresectable(UR-LA)pancreatic cancer that was radically resected after S-1 therapy. A 65-year-old…”
Get more information

Antitumor effects in gastrointestinal stromal tumors using photodynamic therapy with a novel glucose-conjugated chlorin by Tanaka, Mamoru, Kataoka, Hiromi, Yano, Shigenobu, Ohi, Hiromi, Moriwaki, Kazuhiro, Akashi, Haruo, Taguchi, Takahiro, Hayashi, Noriyuki, Hamano, Shingo, Mori, Yoshinori, Kubota, Eiji, Tanida, Satoshi, Joh, Takashi

“…Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Except for surgical resection, no effective…”
Get full text

Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells by Hamano, Shingo, Mori, Yoshinori, Aoyama, Mineyoshi, Kataoka, Hiromi, Tanaka, Mamoru, Ebi, Masahide, Kubota, Eiji, Mizoshita, Tsutomu, Tanida, Satoshi, Johnston, Randal N, Asai, Kiyofumi, Joh, Takashi

“…Highlights • Trastuzumab is effective for HER2-overexpressing gastric cancer therapy. • Oncolytic reovirus is currently undergoing clinical trials…”
Get full text